Position in EXEL
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$6,157,159
-$6,431,605 QoQ
Shares Held
143,557
-50.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,157,159 | 143,557 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $12,588,764 | 287,218 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $28,749,095 | 696,104 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $25,907,446 | 587,737 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $13,111,768 | 355,140 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,468,544 | 614,671 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $14,223,688 | 548,119 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $15,900,558 | 707,635 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $17,927,469 | 755,477 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $17,071,883 | 711,625 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,549,005 | 711,625 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $19,141,282 | 1,001,637 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $29,831,636 | 1,536,921 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $35,978,328 | 2,243,038 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $32,472,542 | 2,070,953 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $39,673,425 | 1,905,544 | Shares | Other | 2022-08-03 | |
| 2022-03-31 | $35,871,103 | 1,582,316 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $48,493,439 | 2,652,814 | Shares | Other | 2022-02-10 | |
| 2021-12-31 | $91,400 | 5,000 | Principal | Sole | 2022-02-10 | |
| 2021-09-30 | $57,898,295 | 2,738,803 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $50,431,993 | 2,767,947 | Shares | Other | 2021-07-20 | |
| 2021-03-31 | $52,168,870 | 2,309,379 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $46,348,573 | 2,309,346 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $29,957,386 | 1,225,251 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $9,289,129 | 391,286 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $11,339,644 | 658,516 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||